FXIII: Prophylactic trials: intervention vs inactive control
Arterial thromboembolic events Post‐operatively · the prevention and treatment of bleeding in patients without haemophilia
FXIII: Prophylactic trials: intervention showed no clear difference in arterial thromboembolic events Up to 5 to 7 weeks post‐operatively compared with inactive control (low certainty).
3 findings from 1 review
- Pro‐coagulant haemostatic factors for the prevention and treatment of bleeding in people without haemophilia 2018 · Cochrane Headline outcomes onlyRR 0.67 [0.28, 1.62]2 studies · 282 participantsLow
- Pro‐coagulant haemostatic factors for the prevention and treatment of bleeding in people without haemophilia 2018 · Cochrane Headline outcomes onlyRR 3 [0.14, 66.53]1 study · 22 participantsLow
- Pro‐coagulant haemostatic factors for the prevention and treatment of bleeding in people without haemophilia 2018 · Cochrane Headline outcomes onlyRR 0.2 [0.01, 3.97]1 study · 50 participantsVery low